Norovirus and Medically Attended Gastroenteritis in U.S. Children
Top Cited Papers
Open Access
- 21 March 2013
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 368 (12) , 1121-1130
- https://doi.org/10.1056/nejmsa1206589
Abstract
Cases of rotavirus-associated acute gastroenteritis have declined since the introduction of rotavirus vaccines, but the burden of norovirus-associated acute gastroenteritis in children remains to be assessed. We conducted active surveillance for laboratory-confirmed cases of norovirus among children younger than 5 years of age with acute gastroenteritis in hospitals, emergency departments, and outpatient clinical settings. The children resided in one of three U.S. counties during the years 2009 and 2010. Fecal specimens were tested for norovirus and rotavirus. We calculated population-based rates of norovirus-associated acute gastroenteritis and reviewed billing records to determine medical costs; these data were extrapolated to the U.S. population of children younger than 5 years of age. Norovirus was detected in 21% of young children (278 of 1295) seeking medical attention for acute gastroenteritis in 2009 and 2010, with norovirus detected in 22% (165 of 742) in 2009 and 20% (113 of 553) in 2010 (P=0.43). The virus was also detected in 4% of healthy controls (19 of 493) in 2009. Rotavirus was identified in 12% of children with acute gastroenteritis (152 of 1295) in 2009 and 2010. The respective rates of hospitalization, emergency department visits, and outpatient visits for the norovirus were 8.6, 146.7, and 367.7 per 10,000 children younger than 5 years of age in 2009 and 5.8, 134.3, and 260.1 per 10,000 in 2010, with an estimated cost per episode of $3,918, $435, and $151, respectively, in 2009. Nationally, we estimate that the average numbers of annual hospitalizations, emergency department visits, and outpatient visits due to norovirus infection in 2009 and 2010 among U.S. children in this age group exceeded 14,000, 281,000, and 627,000, respectively, with more than $273 million in treatment costs each year. Since the introduction of rotavirus vaccines, norovirus has become the leading cause of medically attended acute gastroenteritis in U.S. children and is associated with nearly 1 million health care visits annually. (Funded by the Centers for Disease Control and Prevention.)Keywords
This publication has 30 references indexed in Scilit:
- Severe Outcomes Are Associated With Genogroup 2 Genotype 4 Norovirus Outbreaks: A Systematic Literature ReviewClinical Infectious Diseases, 2012
- Novel Surveillance Network for Norovirus Gastroenteritis Outbreaks, United StatesEmerging Infectious Diseases, 2011
- Incidence of Acute Gastroenteritis and Role of Norovirus, Georgia, USA, 2004-2005Emerging Infectious Diseases, 2011
- Reduction in Gastroenteritis in United States Children and Correlation With Early Rotavirus Vaccine Uptake From National Medical Claims DatabasesThe Pediatric Infectious Disease Journal, 2010
- Molecular Epidemiology of Genogroup II-Genotype 4 Noroviruses in the United States between 1994 and 2006Journal of Clinical Microbiology, 2010
- Demographic Variability, Vaccination, and the Spatiotemporal Dynamics of Rotavirus EpidemicsScience, 2009
- Systematic Literature Review of Role of Noroviruses in Sporadic GastroenteritisEmerging Infectious Diseases, 2008
- Mechanisms of GII.4 Norovirus Persistence in Human PopulationsPLoS Medicine, 2008
- Fecal Viral Concentration and Diarrhea in Norovirus GastroenteritisEmerging Infectious Diseases, 2007
- Fecal Viral Load and Norovirus-associated GastroenteritisEmerging Infectious Diseases, 2006